Ginkgo Bioworks Holdings, Inc.
DNA
$10.97
$0.2051.91%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.89% | 44.71% | 38.73% | 23.98% | 26.65% |
| Total Depreciation and Amortization | -0.18% | 1.71% | -10.62% | -19.95% | 3.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.21% | -51.50% | -48.88% | -33.44% | -42.71% |
| Change in Net Operating Assets | -380.34% | -454.30% | -400.53% | -146.77% | 99.72% |
| Cash from Operations | 22.07% | 4.19% | -8.15% | 2.11% | -2.70% |
| Capital Expenditure | 12.29% | -126.05% | -53.28% | 17.02% | 42.34% |
| Sale of Property, Plant, and Equipment | -69.57% | -89.68% | -89.68% | -36.75% | -47.28% |
| Cash Acquisitions | 100.00% | 100.00% | -- | -107.23% | -107.23% |
| Divestitures | -- | -- | -- | -- | -51.40% |
| Other Investing Activities | -44,596.78% | -13,492.83% | 491.64% | 115.90% | 97.72% |
| Cash from Investing | -221.17% | -239.03% | 22.87% | -2,139.43% | -87.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 37.95% | 36.07% | 30.73% | 22.27% | 10.58% |
| Issuance of Common Stock | -100.00% | -90.73% | -9.68% | -99.90% | -99.85% |
| Repurchase of Common Stock | -- | -- | -- | 97.66% | 97.66% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.68% | 85.00% | 53.49% | 43.01% | 54.37% |
| Cash from Financing | 51.78% | 65.30% | 45.93% | -102.28% | -102.12% |
| Foreign Exchange rate Adjustments | 157.14% | 93.05% | 52.21% | -125.92% | -151.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.31% | -43.17% | -1.01% | -72.62% | -59.31% |